DENTSPLY SIRONA (NASDAQ:XRAY) Posts Quarterly Earnings Results, Misses Expectations By $0.18 EPS

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) released its quarterly earnings data on Monday. The medical instruments supplier reported $0.41 EPS for the quarter, missing the consensus estimate of $0.59 by ($0.18), Briefing.com reports. The business had revenue of $947.00 million during the quarter, compared to analysts’ expectations of $1.01 billion. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The firm’s revenue was down 8.9% on a year-over-year basis. During the same period last year, the company earned $0.68 earnings per share. DENTSPLY SIRONA updated its FY 2022 guidance to $1.90-$2.00 EPS and its FY22 guidance to $1.90-2.00 EPS.

DENTSPLY SIRONA Trading Down 4.8 %

Shares of NASDAQ XRAY traded down $1.55 during trading on Monday, hitting $30.50. 114,017 shares of the company were exchanged, compared to its average volume of 2,242,948. DENTSPLY SIRONA has a 12-month low of $26.48 and a 12-month high of $58.70. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45. The company has a fifty day moving average price of $30.06 and a 200-day moving average price of $34.44. The firm has a market capitalization of $6.55 billion, a PE ratio of 18.96, a P/E/G ratio of 3.46 and a beta of 0.95.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on XRAY. The Goldman Sachs Group cut their price target on DENTSPLY SIRONA from $42.00 to $41.00 and set a “neutral” rating for the company in a research note on Thursday, July 21st. StockNews.com assumed coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, October 12th. They set a “hold” rating for the company. William Blair reissued an “underperform” rating on shares of DENTSPLY SIRONA in a research note on Tuesday, November 1st. Finally, Morgan Stanley cut their price objective on DENTSPLY SIRONA from $44.00 to $42.00 and set an “overweight” rating for the company in a research note on Thursday, October 13th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $47.89.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Parkside Financial Bank & Trust raised its holdings in shares of DENTSPLY SIRONA by 163.7% during the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock worth $46,000 after acquiring an additional 568 shares during the period. Covestor Ltd raised its holdings in DENTSPLY SIRONA by 97.8% in the 1st quarter. Covestor Ltd now owns 3,198 shares of the medical instruments supplier’s stock valued at $157,000 after buying an additional 1,581 shares during the period. KB Financial Partners LLC raised its holdings in DENTSPLY SIRONA by 19.5% in the 1st quarter. KB Financial Partners LLC now owns 4,443 shares of the medical instruments supplier’s stock valued at $219,000 after buying an additional 726 shares during the period. Captrust Financial Advisors raised its holdings in DENTSPLY SIRONA by 14.0% in the 1st quarter. Captrust Financial Advisors now owns 4,446 shares of the medical instruments supplier’s stock valued at $219,000 after buying an additional 546 shares during the period. Finally, Prudential PLC purchased a new stake in DENTSPLY SIRONA in the 1st quarter valued at about $231,000. Hedge funds and other institutional investors own 96.00% of the company’s stock.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Featured Articles

Earnings History for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.